
₹4,382.81 Original price was: ₹4,382.81.₹853.00Current price is: ₹853.00.
Gefshil 250mg Tablet by Arogya delivers high-dose therapy for targeted cancer or chronic disease management, supporting safe and effective treatment.
| Country of Origin | India |
|---|---|
| Manufacturer | SHILPA MEDICARE LTD |
| Pack Size | 10 Tablet(s) In A Strip |
| Product Name | GEFSHIL 250MG TAB |
| SKU | AROG-GFS250 |
| Salt Composition | GEFITINIB |
| Storage | Store at 25°C |
| Strength | 250mg |
Gefshil 250mg Tablet is an antineoplastic medication containing the active ingredient Gefitinib. It belongs to the class of tyrosine kinase inhibitors and is used to treat non-small cell lung cancer (NSCLC). NSCLC is a condition in which cells multiply in an uncontrolled and abnormal manner in lung tissues. Gefshil 250mg is indicated for patients whose cancer has spread to other parts of the body, have certain abnormal epidermal growth factor receptor (EGFR) genes, and have not received previous cancer treatment.
Some formulations may contain lactose. Patients with lactose intolerance should inform their doctor before starting therapy. Consult your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or are taking blood thinners like warfarin. Avoid alcohol as it may increase dizziness.
Pregnancy and breastfeeding are not recommended during treatment. Discuss effective contraception with your doctor and use it for at least two weeks after the last dose. Your healthcare provider may conduct pregnancy testing before starting treatment.
Gefshil 250mg Tablet is used for:
Side effects are unwanted symptoms caused by medicines. Not everyone experiences them.
Common:
Q1. What are the Gefshil 250mg Tablet side effects?
Common side effects include diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, red or itchy eyes, nail problems, hair loss, fever, nosebleed, and burning sensation while urinating.
Q2. Is Gefshil 250mg Tablet a targeted therapy?
Yes, Gefshil 250mg Tablet is a targeted drug therapy used to treat advanced non-small cell lung cancer (NSCLC).
Q3. Who should not use Gefshil 250mg Tablet?
Gefshil 250mg is not indicated for children and adolescents under 18. It should not be used by individuals allergic to Gefitinib, or by pregnant or breastfeeding women.
Q4. Is it safe for women of reproductive potential to use Gefshil 250mg Tablet?
Gefshil 250mg is not recommended during pregnancy or breastfeeding. Inform your healthcare provider if you are pregnant, think you might be pregnant, breastfeeding, or planning pregnancy.
Q5. What should I avoid while taking Gefshil 250mg Tablet?
Avoid taking antacids or stomach acid-reducing medications within two hours before or one hour after taking Gefshil 250mg, as they may interfere with absorption.
Arogya’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Arogya. Our mission is to support, not replace, the doctor-patient relationship.


